IRADIMED CORPORATION
US ˙ NasdaqGM ˙ US46266A1097

SecurityIRMD / IRADIMED CORPORATION
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership32,504 shares
Latest Disclosed Value $ 3,128,835
Citadel Advisors Llc ownership in IRMD / IRADIMED CORPORATION

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 32,504 shares of IRADIMED CORPORATION (US:IRMD) valued at $3,128,835 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 55,758 shares of IRADIMED CORPORATION. This represents a change in shares of -41.71% during the quarter. The current value of the position is $3,025,147 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (IRMD) in the form of stock options. The firm currently holds call options representing 14,700 of underlying shares valued at $1,415,022 USD and put options representing 5,800 of underlying shares valued at $558,308 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IRMD / IRADIMED CORPORATION Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IRADIMED COM 46266A109 32,504 -23,254 -41.71 3,129 -42.33 0.0004
2026-02-17 2025-12-31 13F IRADIMED COM 46266A109 55,758 22,031 65.32 5,424 126.00 0.0008
2025-11-14 2025-09-30 13F IRADIMED COM 46266A109 33,727 30,320 889.93 2,400 1,082.27 0.0004
2025-08-14 2025-06-30 13F IRADIMED COM 46266A109 3,407 3,407 204 0.0000
2025-05-15 2025-03-31 13F IRADIMED COM 46266A109 0 -5,304 -100.00 0 -100.00
2025-02-14 2024-12-31 13F IRADIMED COM 46266A109 5,304 5,304 292 0.0001
2024-11-14 2024-09-30 13F IRADIMED COM 46266A109 0 -17,750 -100.00 0 -100.00
2024-08-14 2024-06-30 13F IRADIMED COM 46266A109 17,750 -14,003 -44.10 780 -44.20 0.0002
2024-05-15 2024-03-31 13F IRADIMED COM 46266A109 31,753 11,527 56.99 1,397 45.42 0.0003
2024-02-14 2023-12-31 13F IRADIMED COM 46266A109 20,226 2,695 15.37 960 23.55 0.0002
2023-11-14 2023-09-30 13F IRADIMED COM 46266A109 17,531 -16,346 -48.25 778 -51.95 0.0002
2023-08-14 2023-06-30 13F IRADIMED COM 46266A109 33,877 -18,383 -35.18 1,617 -21.35 0.0003
2023-05-15 2023-03-31 13F IRADIMED COM 46266A109 52,260 37,115 245.06 2,056 380.37 0.0005
2023-02-14 2022-12-31 13F IRADIMED COM 46266A109 15,145 15,145 428 0.0001
2022-08-15 2022-06-30 13F IRADIMED COM 46266A109 0 -5,617 -100.00 0 -100.00
2022-05-16 2022-03-31 13F IRADIMED COM 46266A109 5,617 5,617 252 0.0001
2022-02-14 2021-12-31 13F IRADIMED Cmn 46266A109 0 -7,086 -100.00 0 -100.00
2021-11-15 2021-09-30 13F IRADIMED Cmn 46266A109 7,086 7,086 238 0.0000
2021-02-16 2020-12-31 13F IRADIMED COM 46266A109 0 -12,610 -100.00 0 -100.00
2020-11-16 2020-09-30 13F IRADIMED COM 46266A109 12,610 -11,118 -46.86 270 -50.91 0.0001
2020-08-14 2020-06-30 13F IRADIMED Cmn 46266A109 23,728 3,682 18.37 550 28.50 0.0002
2020-05-15 2020-03-31 13F IRADIMED Cmn 46266A109 20,046 20,046 428 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IRADIMED COM Call 14,700 1,415 n/a n/a n/a
2025-05-15 2025-03-31 13F IRADIMED COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F IRADIMED COM Call 600 33 n/a n/a n/a
2024-11-14 2024-09-30 13F IRADIMED COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F IRADIMED COM Call 1,600 -33.33 70 -33.33 n/a n/a n/a
2024-05-15 2024-03-31 13F IRADIMED COM Call 2,400 0.00 106 -7.08 n/a n/a n/a
2024-02-14 2023-12-31 13F IRADIMED COM Call 2,400 114 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IRADIMED COM Put 5,800 558 n/a n/a n/a
2026-02-17 2025-12-31 13F IRADIMED COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F IRADIMED COM Put 5,300 377 n/a n/a n/a
2025-05-15 2025-03-31 13F IRADIMED COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F IRADIMED COM Put 900 50 n/a n/a n/a
2024-11-14 2024-09-30 13F IRADIMED COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F IRADIMED COM Put 100 -95.00 4 -95.40 n/a n/a n/a
2024-05-15 2024-03-31 13F IRADIMED COM Put 2,000 25.00 88 16.00 n/a n/a n/a
2024-02-14 2023-12-31 13F IRADIMED COM Put 1,600 76 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.